尊龙时凯

2019/05/16

Johnson & Johnson Outlines Strategy to Deliver Above-Market Growth at 2019 Pharmaceutical Business Review

Highlights progress and commitment to deliver breakthrough medicines to meet the needs of patients around the worldPlans to maximize potential of leading brands by filing more than 40 line extensions ...

2018/03/27

Janssen joins partnership in China to provide access to SIRTURO® (bedaquiline) for the treatment of multidrug-resistant tuberculosis (MDR-TB)

As part of the partnership, Xian Janssen will donate 1,000 courses of SIRTURO® through New Drug Introduction and Protection Program

2018/01/23

IMBRUVICA and REMICADE included on the Zhejiang Province Reimbursement List for Drugs Treating Major Illnesses

Xian Janssen Pharmaceutical Ltd.

2017/11/13

XIAN JANSSEN LAUNCHES EARLY IMBRUVICA® (IBRUTINIB)

BEIJING, November 12, 2017 - Xian Janssen Pharmaceutical Ltd.

2017/09/25

【ChinaDaily】Serving in the name of progress

A senior executive at Johnson & Johnson talks about the group's strategy in China and the rest of the worldJoaquin Duato had dreams of playing tennis for Spain as a child.

2017/09/21

Xian Janssen and Shaanxi Province Forestry Department Announce a New Phase of Collaboration to Protect Giant Pandas

[September 21, 2017, Xi'an] – Today, Xian Janssen Pharmaceuticals, Ltd., kicked off a new phase of cooperation with the Shaanxi Academy of Forestry Qinling Mountains Giant Panda Breeding Center to pro...

2017/07/19

Xian Janssen: VELCADE® and ZYTIGA® Included on the NRDL 2017

[Beijing, July 19, 2017] Xian Janssen Pharmaceutical Ltd.

2017/05/19

Johnson & Johnson Showcases Strong Pipeline of Transformational Medicines at its Pharmaceutical Business Review Meeting

Company expects more than 10 new blockbuster products to launch or file for regulatory approval by 2021More than 50 line-extension regulatory filings projected by 2021Beyond 2021, early-stage pipeline...

2017/03/21

Xian Janssen launches Lung Tree Care Initiative and commits to combating tuberculosis

[17 March 2017, Beijing] – Ahead of World TB Day 2017, Xian Janssen Pharmaceutical Ltd., today launched a new initiative called Lung Tree Care to help tackle tuberculosis (TB) and Multidrug-resis...

2017/02/22

ZYTIGA®, DACOGEN and REMICADE® included in the Catalogue of Medical Insurance Special Drugs for Major Illnesses in Chengdu

Cost of treatment for eligible patients with metastatic Castration Resistant Prostate Cancer, Myelodysplastic Syndrome, Ankylosing Spondylitis and Rheumatoid Arthritis now reimbursed in Chengdu(Feb. 2...